Cargando…
Chronic kidney disease with elevated myocardial native T1 – Is this only due to myocardial fibrosis?
Autores principales: | Ng, Ming-Yen, Yap, Pui Min, Yiu, Kai Hang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656919/ https://www.ncbi.nlm.nih.gov/pubmed/31372491 http://dx.doi.org/10.1016/j.ijcha.2019.100403 |
Ejemplares similares
-
Insights into Myocardial Fibrosis in Advanced Chronic Kidney Disease Using Human Tissue
por: Mondal, Nandan K., et al.
Publicado: (2023) -
The simpler, the better: culprit-only intervention is beneficial in patients with chronic kidney disease with concurrent acute myocardial infarction and multivessel disease
por: Jo, Sang-Ho
Publicado: (2015) -
Completing the job: The advantage of complete revascularization in ST-elevation myocardial infarction over culprit-only revascularization strategies
por: Moroni, Francesco, et al.
Publicado: (2020) -
Aortic stiffness is independently associated with interstitial myocardial fibrosis by native T1 and accelerated in the presence of chronic kidney disease()
por: Chen, Mengzhen, et al.
Publicado: (2019) -
Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)